ARENTFOX SCHIFF LLP for AMERICAN PHARMACY COOPERATIVE, INC.
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Policies regarding transparency in prescription drug pricing and patient access to care in Medicare, Medicaid, and other insurance Pharmacy Benefit Manager (PBM) reform generally H.R. 9096 (Pharmacists Fight Back Act), regarding Pharmacy Benefit Manager (PBM) reform, all provisions
| Lobbyist | Covered position, as disclosed |
|---|---|
| CISSY JACKSON | — |
| DANIEL SJOSTEDT | — |
| OLIVER SPURGEON III | — |
Pharmacy PHA
Prescription drug pricing generally Pharmacy Benefit Manager (PBM) reform generally S. 2973 (Modernizing and Ensuring PBM Accountability Act), all provisions S. 1339 (Pharmacy Benefit Manager Reform Act), regarding Pharmacy Benefit Manager (PBM) reform S. 3430 (Better Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023), regarding Pharmacy Benefit Manager (PBM) reform H.R. 5378 (Lower Costs, More Transparency Act), regarding Pharmacy Benefit Manager (PBM) reform H.R. 6283 (DRUG Act), regarding Pharmacy Benefit Manager (PBM) reform H.R. 9096 (Pharmacists Fight Back Act), regarding Pharmacy Benefit Manager (PBM) reform, all provisions
| Lobbyist | Covered position, as disclosed |
|---|---|
| CISSY JACKSON | — |
| DANIEL SJOSTEDT | — |
| OLIVER SPURGEON III | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.